GSK GlaxoSmithKline PLC ADRs

GlaxoSmithKline PLC creates, discovers, develops, manufactures and markets pharmaceutical products including respiratory and antiviral, vaccines, over-the-counter (OTC) medicines and health-related consumer products. This is an ADR of a company whose stock trades outside of the U.S. as the symbol LN:GSK.

$35.30  -0.04 (-0.11%)
As of 01/27/2023 16:00:01 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  ADRs
Category3:  Large cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—General
Index country:  United Kingdom
Country of incorporation:  United Kingdom
IPO date:  09/04/2001
Outstanding shares:  2,047,099,466
Average volume:  3,668,571
Market cap:   $72,385,437,118
Current dividend yield:  5.24%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      2374112

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%